FindTrial
Sign In

Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease

Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease - Efficacy of fecal microbiota transplantation in patients with inflammatory bowel disease

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021399
Enrollment
10
Registered
2016-04-01
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

fecal microbiota transplantation

Sponsors

Kinki university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as mild - moderate inflammatory bowel disease (ulcerative colitis, crohn disease, bechet disease) at our hospital and refractory to standard treatments

Exclusion criteria

Exclusion criteria: Patients with severe inflammatory bowel disease, those who are considered inappropriate by physicians, or those who do not agree with entering the study.

Design outcomes

Primary

MeasureTime frame
To assess the rate of remission induction of patients treated with fecal microbiota transplantation—

Countries

Japan

Contacts

Public ContactToshiharu Sakurai

Kinki university Gastroenterology

sakurai@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026